Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
0.804
+0.086 (11.92%)
Dec 26, 2024, 2:04 PM EST - Market open

Ocugen Revenue

Ocugen had revenue of $1.14M in the quarter ending September 30, 2024, a decrease of -69.29%. This brings the company's revenue in the last twelve months to $4.70M, down -33.94% year-over-year. In the year 2023, Ocugen had annual revenue of $6.04M with 142.60% growth.

Revenue (ttm)
$4.70M
Revenue Growth
-33.94%
P/S Ratio
40.10
Revenue / Employee
$72,308
Employees
65
Market Cap
234.16M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20236.04M3.55M142.60%
Dec 31, 20222.49M--
Dec 31, 2021---
Dec 31, 202043.00K--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MacroGenics 141.33M
Biodesix 65.56M
SOPHiA GENETICS 64.49M
Utah Medical Products 44.08M
Inventiva 20.65M
Profound Medical 8.98M
Inhibrx Biosciences 1.57M
Atai Life Sciences 331.00K
Revenue Rankings